Trademark: 88133406
Status Date
Tuesday, January 7, 2020
Registration Number
5952886
Registration Date
Tuesday, January 7, 2020
Filing Date
Wednesday, September 26, 2018
Published for Opposition
Tuesday, October 22, 2019
5 Pharmaceutical preparations for use in treating diseases of the cardiovascular system and cerebrovascular system; Pharmaceutical preparations for use in treating cancerous tumors; Pharmaceutical preparations for use in treating metabolic diseases and diseases of the immune system and the musculo-skeletal system; Chemical preparations for pharmaceutical or medical purposes, namely, Pharmaceutical preparations for use in haematology, dermatology, ophthalmology and gastroenterology, Pharmaceutical preparations being anti-infectives, Pharmaceutical preparations for use in treating diseases of the respiratory system, the digestive system, and the endocrine system, Pharmaceutical preparations for use in treating hypersensitivity diseases; Medicines for human purpose for treating disease, namely, pharmaceutical preparations for use in treating diseases of the cardiovascular system and cerebrovascular system, pharmaceutical preparations for use in treating cancerous tumors, pharmaceutical preparations for use in treating metabolic diseases, as well as diseases of the immune system and the musculo-skeletal system; Active pharmaceutical ingredients in the nature of pharmaceutical preparations used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, and the musculo-skeletal system, and for treating cancerous tumors; Biochemical medicines for use in treating diseases of the cardiovascular system and cerebrovascular system; Biochemical medicines for use in treating cancerous tumors; Biochemical medicines for use in treating metabolic diseases, nervous system diseases as well as diseases of the immune system and the musculo-skeletal system; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the metabolic system, the respiratory system, and the musculo-skeletal system, pharmaceutical preparations for use in tissue and organ transplantation, for use in ophthalmology and for use in treatment of gastroenterological disorders
Jan 7, 2020
Registered-Principal Register
Oct 22, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 22, 2019
Published For Opposition
Oct 2, 2019
Notification Of Notice Of Publication E-Mailed
Sep 18, 2019
Approved For Pub - Principal Register
Aug 9, 2019
Examiner's Amendment Entered
Aug 9, 2019
Notification Of Examiners Amendment E-Mailed
Aug 9, 2019
Examiners Amendment E-Mailed
Aug 9, 2019
Examiners Amendment -Written
Aug 7, 2019
Teas Voluntary Amendment Received
Aug 6, 2019
Teas/Email Correspondence Entered
Aug 6, 2019
Correspondence Received In Law Office
Aug 6, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 6, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 5, 2019
Assigned To Lie
Jul 31, 2019
Notice Of Revival - E-Mailed
Jul 30, 2019
Teas Response To Office Action Received
Jul 30, 2019
Petition To Revive-Granted
Jul 30, 2019
Teas Petition To Revive Received
Jul 29, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 29, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 10, 2019
Teas Change Of Correspondence Received
Jan 17, 2019
Notification Of Non-Final Action E-Mailed
Jan 17, 2019
Non-Final Action E-Mailed
Jan 17, 2019
Non-Final Action Written
Jan 16, 2019
Applicant Amendment Prior To Examination - Entered
Jan 16, 2019
Teas Voluntary Amendment Received
Jan 8, 2019
Assigned To Examiner
Oct 4, 2018
New Application Office Supplied Data Entered In Tram
Sep 29, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
